Trends in utilization of tramadol and other opioids in Denmark 2017–2023: A nationwide drug utilization study

The use of tramadol and other opioids for pain management has been accompanied by a multitude of challenges and concerns worldwide. The use of tramadol saw a decline in Denmark during 2017–2019 accompanied by a slight increase in the use of morphine and oxycodone. Using the Danish National Prescript...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:British journal of clinical pharmacology Ročník 91; číslo 3; s. 908 - 913
Hlavní autori: Rasmussen, Lotte, Ernst, Martin Thomsen, Forberg, Solveig, Pottegård, Anton, Søndergaard, Jens, Sørensen, Anne Mette Skov
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: England 01.03.2025
Predmet:
ISSN:0306-5251, 1365-2125, 1365-2125
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:The use of tramadol and other opioids for pain management has been accompanied by a multitude of challenges and concerns worldwide. The use of tramadol saw a decline in Denmark during 2017–2019 accompanied by a slight increase in the use of morphine and oxycodone. Using the Danish National Prescription Registry and utilizing data until and including 2023, we aimed to provide updated data on the utilization patterns of tramadol and other opioids in Denmark. We found a 35% decline in the use of tramadol from 2017 to 2023 most likely due to media attention, regulatory actions, health campaigns and targeted education of physicians and patients by the Danish health authorities. This decline was accompanied by an increase in the number of new (+90%) and current users of morphine (+57%), which surpassed those of tramadol, oxycodone and other opioids in 2023.
Bibliografia:Funding information
None.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0306-5251
1365-2125
1365-2125
DOI:10.1111/bcp.16360